Population screening for hereditary haemochromatosis in Australia: Construction and validation of a state-transition cost-effectiveness model

Barbara De Graaff; Lei Si; Amanda L. Neil; Kwang Chien Yee; Kristy Sanderson; Lyle C. Gurrin; Andrew J. Palmer

doi:10.1007/s41669-016-0005-0

Population screening for hereditary haemochromatosis in Australia: Construction and validation of a state-transition cost-effectiveness model

Barbara De Graaff, Lei Si, Amanda L. Neil, Kwang Chien Yee, Kristy Sanderson, Lyle C. Gurrin, Andrew J. Palmer

Research output: Contribution to journal › Article › peer-review

5 Citations (Scopus)

13 Downloads (Pure)

Original language	English
Pages (from-to)	37-51
Journal	PharmacoEconomics - Open
Volume	1
Issue number	1
Early online date	16 Nov 2016
DOIs	https://doi.org/10.1007/s41669-016-0005-0
Publication status	Published - Mar 2017

Access to Document

10.1007/s41669-016-0005-0Licence: CC BY

PharmacoEconomics-OpenFinal published version, 1.28 MBLicence: CC BY

http://link.springer.com/10.1007/s41669-016-0005-0Licence: CC BY

Cite this

@article{7e96da3346e54463badebd03f72f0467,

title = "Population screening for hereditary haemochromatosis in Australia: Construction and validation of a state-transition cost-effectiveness model",

author = "{De Graaff}, Barbara and Lei Si and Neil, {Amanda L.} and Yee, {Kwang Chien} and Kristy Sanderson and Gurrin, {Lyle C.} and Palmer, {Andrew J.}",

year = "2017",

month = mar,

doi = "10.1007/s41669-016-0005-0",

language = "English",

volume = "1",

pages = "37--51",

journal = "PharmacoEconomics - Open",

issn = "2509-4262",

publisher = "Springer",

number = "1",

}

TY - JOUR

T1 - Population screening for hereditary haemochromatosis in Australia: Construction and validation of a state-transition cost-effectiveness model

AU - De Graaff, Barbara

AU - Si, Lei

AU - Neil, Amanda L.

AU - Yee, Kwang Chien

AU - Sanderson, Kristy

AU - Gurrin, Lyle C.

AU - Palmer, Andrew J.

PY - 2017/3

Y1 - 2017/3

U2 - 10.1007/s41669-016-0005-0

DO - 10.1007/s41669-016-0005-0

M3 - Article

SN - 2509-4262

VL - 1

SP - 37

EP - 51

JO - PharmacoEconomics - Open

JF - PharmacoEconomics - Open

IS - 1

ER -